Citation: Am. Kijak et al., Strengthening silica prepared by sol-gel chemistry by inclusion of a polyamidoamine dendrimer, J SOL-GEL S, 21(3), 2001, pp. 213-219
Authors:
Schultz, C
Richter, N
Moller, JC
Bucsky, P
Citation: C. Schultz et al., IFN-gamma response and IL-8 plasma levels in neonates with respiratory syncytial virus bronchiolitis, EUR RESP J, 17(2), 2001, pp. 321-322
Citation: Jc. Moller, Use of heparin-bonded central-venous catheters in critically ill children - Reduced risk for thrombosis and catheter-associated infections, MONATS KIND, 149(3), 2001, pp. 304-305
Authors:
Kalla, R
Liu, ZQ
Xu, SL
Koppius, A
Imai, Y
Kloss, CUA
Kohsaka, S
Gschwendtner, A
Moller, JC
Werner, A
Raivich, G
Citation: R. Kalla et al., Microglia and the early phase of immune surveillance in the axotomized facial motor nucleus: Impaired microglial activation and lymphocyte recruitment but no effect on neuronal survival or axonal regeneration in macrophage-colony stimulating factor-deficient mice, J COMP NEUR, 436(2), 2001, pp. 182-201
Authors:
Moller, JC
Stiasny, K
Cassel, W
Peter, JH
Kruger, HP
Oertel, WH
Citation: Jc. Moller et al., "Sleep attacks" in parkinsonian patients: a side effect of nonergoline dopamine agonists or a class effect of dopamimetic agents?, NERVENARZT, 71(8), 2000, pp. 670-676
Authors:
Moller, JC
Kohl, M
Reiss, I
Diederich, W
Nitsche, EM
Gopel, W
Gortner, L
Citation: Jc. Moller et al., Saline lavage with substitution of bovine surfactant in term neonates withmeconium aspiration syndrome (MAS) transferred for extracorporeal membraneoxygenation (ECMO): a pilot study, CRIT CARE, 3(1), 1999, pp. 19-22
Authors:
Moller, JC
Reiss, I
Schaible, TF
Kohl, M
Gopel, W
Fischer, T
Nitsche, EM
Kruger, S
Citation: Jc. Moller et al., Oxygenation and lung morphology in a rabbit pediatric ARDS- model under high peak pressure ventilation plus nitric oxide and surfactant compared withveno-venous ECMO, INT J ARTIF, 22(11), 1999, pp. 747-753
Authors:
Kunig, G
Pogarell, O
Moller, JC
Delf, M
Oertel, WH
Citation: G. Kunig et al., Pramipexole, a nonergot dopamine agonist, is effective against rest tremorin intermediate to advanced Parkinson's disease, CLIN NEUROP, 22(5), 1999, pp. 301-305
Authors:
Klein, RL
Muir, D
King, MA
Peel, AL
Zolotukhin, S
Moller, JC
Kruttgen, A
Heymach, JV
Muzyczka, N
Meyer, EM
Citation: Rl. Klein et al., Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and trk receptor levels in the adult rat basal forebrain, NEUROSCIENC, 90(3), 1999, pp. 815-821
Authors:
Moller, JC
Austing, A
Pust, B
Kohl, M
Reiss, I
Iven, H
Gortner, L
Citation: Jc. Moller et al., A controlled clinical study comparing doxapram and theophylline in the treatment of apneas of prematurity, KLIN PADIAT, 211(2), 1999, pp. 86-91
Citation: Te. Eichhorn et al., Management of adverse effects and other problems of the autonomic nervous system in patients with Parkinson's disease, PARKINSON'S DISEASE: THE TREATMENT OPTIONS, 1999, pp. 187-196
Authors:
Kruttgen, A
Moller, JC
Heymach, JV
Shooter, EM
Citation: A. Kruttgen et al., Neurotrophins induce release of neurotrophins by the regulated secretory pathway (vol 95, pg 9614, 1998), P NAS US, 95(26), 1998, pp. 15867-15867